Cargando…
Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma
Metabolic reprogramming for adaptation to the tumor microenvironment is recognized as a hallmark of cancer. Although many altered metabolic genes have been reported to be associated with tumor pathological processes, systematic analysis of metabolic genes implicated in hepatocellular carcinoma progn...
Autores principales: | Cui, Lijuan, Xue, Huan, Wen, Zhitong, Lu, Zhihong, Liu, Yunfeng, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695384/ https://www.ncbi.nlm.nih.gov/pubmed/33188160 http://dx.doi.org/10.18632/aging.104122 |
Ejemplares similares
-
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
por: Zhao, Xin, et al.
Publicado: (2021) -
Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023) -
Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018) -
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma
por: Ye, Fengdan, et al.
Publicado: (2018) -
The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
por: Liao, Wenwei, et al.
Publicado: (2022)